There are no HIV vaccines currently available, and after the recent failures of three experimental vaccines in development, there are now zero candidates in late-stage trials.

The Food and Drug Administration on Tuesday approved another bivalent COVID-19 booster dose for older adults and people with weak immune systems in an effort to bolster protection against the virus this spring.

Director of UArizona Health Sciences’ Asthma and Airway Center has deep connection to making sure everyone breathes easier.

The U.S. Supreme Court said Friday it would temporarily keep in place federal regulations for use of mifepristone, while it considers issues raised by a federal judge's ruling that suspended FDA approval of the medication and its use in abortion procedures.

Adding pembrolizumab to chemotherapy with or without bevacizumab can help patients with persistent, recurrent, or metastatic cervical cancer “live longer and better,” according to a study.

Recently, the University of Arizona’s One Health Research Initiative awarded graduate research assistantships to two doctoral students conducting research at the College of Veterinary Medicine.

Comprehensive Pain and Addiction Center researchers are studying how electronic stimulation of the brain can break looping pain signals and destructive cravings.

A University of Arizona Health Sciences study uncovered new ways in which Hsp90-inhibitor drugs in the spinal cord are showing promise as potential pain therapeutics.

The COVID-19 pandemic led to an increase in remote jobs, hybrid work and work-from-home arrangements. While these options present flexibility that can be beneficial, they can also disrupt people's sleep patterns and make it challenging to achieve work-life balance.